Bacil Pharma Limited has formally intimated the Bombay Stock Exchange (BSE) about the incorporation of a wholly owned subsidiary company. This communication is made pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and serves as a continuation of a previous letter dated July 7, 2026.
The subsidiary has been incorporated under the name Bacil Research & Development Private Limited. The Certificate of Incorporation was issued by the Central Registration Centre, Ministry of Corporate Affairs, Government of India, on July 28, 2026, under the Companies Act, 2013. The company is a private company limited by shares.
Key Details of the Subsidiary:
- Corporate Identity Number (CIN): U72100MH2026PTC474072
- Permanent Account Number (PAN): AAOCB9909L
- Tax Deduction and Collection Account Number (TAN): MUMB40406C
- Registered Office Address: G2 Samarpan Complex, Link Road Opp. Satam Wadi, Sahar P & T Colony, Mumbai, Maharashtra 400099
The disclosure was signed and submitted digitally by Ms. Chaitali Kalpataru Shah, Director & CFO (DIN: 11167778) of Bacil Pharma Limited.